Vantage Secures Relations with European Sponsors – Awarded Multiple Phase I Studies
MONTRÉAL, QUÉBEC, June 15, 2010 –Vantage BioTrials, Inc., a leading global provider of clinical trial development and management services, announced today that it has secured relations with several European Sponsor’s and as a result has been awarded Phase I studies to be performed within Canada & US for Project Management and Clinical Monitoring services.
About Vantage BioTrials Inc.
Vantage BioTrials Inc. is a privately owned Clinical Research Organization (CRO) based in Montréal Canada that provides superior trial management services and combines a precise blend of clinical development knowledge, talent and resources that will ensure a clinical study’s full potential.
By servicing our Pharmaceutical, Biotech and Generic clients who perform Phase I-IV clinical trials across North America, Europe and Asia, our goal is to exceed their expectations by offering outstanding monitoring, project management and clinical operation services. Our flexibility helps us optimize functionality and improve operational efficiencies for any clinical trial. Our associates are distinguished by their technical expertise and wide range of therapeutic backgrounds, combining with their hands-on experiences, thereby ensuring that our clients receive the highest quality of professional service.
For more information about this news or Vantage BioTrials Inc., please contact:
Viken Bartekian
Vice President, Business Development
Vantage BioTrials Inc.
Phone: (450) 314 2596
Fax: (450) 314 2596
Mobile: (514) 824 5823
[email protected]